Abstract
Intrathecal injection of metergoline reduced the response latencies in the tail-flick and hot-plate tests, supporting the contention that descending 5-hydroxytryptamine (5-HT) pathways tonically inhibit pain sensitivity. Elevated latencies were, however, observed after both intraperitoneal (IP) and intracerebroventricular (ICV) injections in the hot-plate test, when hindpaw lick was used as the response criterion. These findings may indicate that supraspinal 5-HT pathways tonically increase pain responsiveness in certain test situations. Alternative hypotheses are that metergoline in supraspinal structures acts as an agonist at post-synaptic 5-HT receptors mediating antinociception, or as an antagonist at pre-synaptic 5-HT receptors. Recording of first reaction latencies on the hot-plate showed increased thresholds after IP, but not after ICV injections. This may indicate an action on 5-HT receptors in the brain not accessible after ICV injections, or that the effect is mediated by blockade of peripheral 5-HT receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baumann PA, Waldmeier PC (1981) Further evidence for negative feedback control of serotonin release in the central nervous system. Naunyn-Schmiedeberg's Arch Pharmacol 317:36–43
Beretta C, Glasser AH, Nobili MB, Silvestri R (1965) Antagonism of 5-hydroxytryptamine-induced bronchospasm in guinea-pigs by 8β-carbobenzyloxyaminomethyl-1,6-dimethyl-10α-ergoline. J Pharm Pharmacol 17:423–428
Berge O-G (1982) Effects of 5-HT receptor agonists and antagonists on a reflex response to radiant heat in normal and spinally transected rats. Pain 13:253–266
Berge O-G, Fasmer OB, Flatmark T, Hole K (1983a) Time course of changes in nociception after 5,6-dihydroxytryptamine lesions of descending 5-HT pathways. Pharmacol Biochem Behav 18:636–643
Berge O-G, Fasmer OB, Hole K (1983b) Serotonin receptor antagonists induce hyperalgesia without preventing morphine antinociception. Pharmacol Biochem Behav 19:873–878
Bourgoin S, Artaud F, Bockaert J, Hery F, Glowinski J, Hamon M (1978) Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor blocker. Naunyn-Schmiedeberg's Arch Pharmacol 302:313–321
Colpaert FC, Niemegeers CJE, Janssen PAJ (1979) In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists. Eur J Pharmacol 58:505–509
D'Amour FE, Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74–79
Eddy NB, Leimbach D (1953) Synthetic analgesics. II. Dithienyl-butenyl-and dithienylbutylamines. J Pharmacol Exp Ther 107:385–393
Ennis C, Cox B (1982) Pharmacological evidence for the existence of two distinct serotonin receptors in rat brain. Neuropharmacology 21:41–44
Ennis C, Kemp JD, Cox B (1981) Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J Neurochem 36:1515–1520
Fuxe K, Agnati L, Everitt B (1975) Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors. Neurosci Lett 1:283–290
Griersmith BT, Duggan AW, North RA (1981) Methysergide and supraspinal inhibition of the spinal transmission of nociceptive information in the anaesthetized cat. Brain Res 204:147–158
Göthert M (1980) Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of of the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 314:223–230
Haigler HJ, Aghajanian GK (1974) Peripheral serotonin antagonists: Failure to antagonize serotonin in brain areas receiving a prominent serotonergic input. J Neural Transm 35:257–273
Haley TJ, McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 12:12–15
Herman ZS (1975) Behavioural changes induced in conscious mice by intracerebroventricular injection of catecholamines, acetylcholine and 5-hydroxytryptamine. Br J Pharmacol 55:351–358
Hole K, Lorens SA (1975) Response to electric shock in rats: Effects of selective midbrain raphe lesions. Pharmacol Biochem Behav 3:95–102
Hole K, Fuxe K, Jonsson G (1976) Behavioural effects of 5,7-dihydroxytryptamine lesions of ascending 5-hydroxytryptamine pathways. Brain Res 107:385–399
Hylden JLK, Wilcox GL (1980) Intrathecal morphine in mice: A new technique. Eur J Pharmacol 67:313–316
Lin M-T, Chandra A, Chi M-L, Kau C-L (1980) Effects of increasing serotonergic receptor activity in brain on analgesic activity in rats. Exp Neurol 68:548–554
Malec D, Langwinski R (1980) The influence of 5-HT receptor blocking agents on the behavioural effects of analgesics in rats. Psychopharmacology 69:79–83
Messing RB, Lytle LD (1977) Serotonin-containing neurons: Their possible role in pain and analgesia. Pain 4:1–21
Mounsey I, Brady KA, Carroll J, Fisher R, Middlemiss DN (1982) K+-evoked [3H]-5-HT release from rat frontal cortex slices: The effect of 5-HT agonists and antagonists. Biochem Pharmacol 31:49–53
Nakano T, Taira N (1976) 5-Hydroxytryptamine as a sensitizer of somatic nociceptors for pain-producing substances. Eur J Pharmacol 38:23–29
Proudfit HK (1980) Reversible inactivation of raphe magnus neurons: effects on nociceptive threshold and morphine-induced analgesia. Brain Res 201:459–464
Proudfit HK, Hammond DL (1981) Alterations in nociceptive threshold and morphine-induced analgesia produced by intrathecally administered amine antagonists. Brain Res 218:393–399
Rochat C, Cervo L, Romandini S, Samanin R (1982) Differences in the effects of d-fenfluramine and morphine on various responses of rats to painful stimuli. Psychopharmacology 76:188–192
Samanin R, Bernasconi S, Quattrone A (1976) Antinociceptive action of quipazine: Relation to central serotonergic receptor stimulation. Psychopharmacologia 46:219–222
Sastry BSR, Phillis JW (1977) Metergoline as a selective 5-hydroxytryptamine antagonist in the cerebral cortex. Can J Physiol Pharmacol 55:130–133
Simansky KJ, Harvey JA (1981) Altered sensitivity to footshock after selective serotonin depletion: Comparison of electrolytic lesions and neurotoxin injections in the medial forebrain bundle of the rat. J Comp Physiol Psychol 95:341–350
Soja PJ, Sinclair JG (1980) Evidence against a serotonin involvement in the tonic descending inhibition of nociceptor-driven neurons in the cat spinal cord. Brain Res 199:225–230
Spano PF, Biggio G, Casu M, Gessa GL, Bareggi SR, Govoni S, Trabucchi M (1978) Interaction of metergoline with striatal dopamine system. Life Sci 23:2383–2392
Yaksh TL, Wilson PR (1979) Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther 208:446–453
York JL, Maynert EW (1978) Alterations in morphine analgesia produced by chronic deficits of brain catecholamines or serotonin: Role of analgesimetric procedure. Psycho-pharmacology 56:119–125
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fasmer, O.B., Berge, O.G. & Hole, K. Metergoline elevates or reduces nociceptive thresholds in mice depending on test method and route of administration. Psychopharmacology 82, 306–309 (1984). https://doi.org/10.1007/BF00427675
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427675